What's Happening?
The Centers for Medicare and Medicaid Services (CMS) has proposed a new rule aimed at reshaping Medicare payments for outpatient care, particularly targeting the 340B drug discount program. This program allows eligible hospitals to purchase outpatient drugs
at reduced prices, primarily benefiting hospitals serving low-income and uninsured patients. The proposed changes would reduce Medicare reimbursements for drugs acquired through the 340B program starting in 2027. Additionally, CMS plans to expand site-neutral payment policies, which would standardize payments for certain outpatient services regardless of whether they are performed in hospital outpatient departments or physician offices. The proposal is part of CMS's draft 2027 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center payment rule, which is subject to a public comment process before finalization.
Why It's Important?
The proposed changes by CMS are significant as they aim to lower healthcare costs for Medicare beneficiaries, particularly older Americans who face rising premiums and drug prices. By aligning drug payments with actual acquisition costs and eliminating site-of-care disparities, the proposal could reduce out-of-pocket expenses for beneficiaries. However, hospitals have expressed concerns that the cuts could undermine funding for safety-net providers that serve vulnerable populations. The long-term impact of these changes could lead to hospitals seeking alternative revenue sources, potentially affecting the availability and cost of healthcare services. The proposal reflects ongoing efforts to make healthcare more affordable while balancing the financial sustainability of hospitals.
What's Next?
The proposed rule will undergo a public comment period before a final version is issued. If approved, the changes would take effect in 2027. Stakeholders, including hospitals and patient advocacy groups, are likely to engage in discussions and provide feedback during the comment period. The outcome of this process will determine the final structure of the rule and its implementation. The healthcare industry will closely monitor the developments, as the changes could set a precedent for future Medicare payment policies.
